Taiwan FDA registration 518097e74b2b0b88cf70479b00611200

Bilicon cholesterol test tablets (unsterilized)

TW: 必立康膽固醇測試片(未滅菌)

Taiwan·Risk Class 1·APEX BIOTECHNOLOGY CORPORATION·Registered Nov 14, 2019 – Nov 14, 2029Active

Registration details

Analysis ID: 518097e74b2b0b88cf70479b00611200

Company information

Manufacturer: APEX BIOTECHNOLOGY CORPORATION
Manufacturer Country: Taiwan, Province of China
Authorized Representative: APEX BIOTECHNOLOGY CORPORATION

Product details

Intended Use: Limited to the first level identification range of the "Cholesterol (Total) Test System (A.1175)" of the Measures for the Classification and Grading Management of Medical Equipment.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1175 Cholesterol (Total) Testing System
Import Information: 國產;; QMS/QSD

Dates and status

Registration Date: Nov 14, 2019
Expiry Date: Nov 14, 2029

About this record

Access comprehensive regulatory information for Bilicon cholesterol test tablets (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 518097e74b2b0b88cf70479b00611200 and manufactured by APEX BIOTECHNOLOGY CORPORATION. The authorized representative in Taiwan is APEX BIOTECHNOLOGY CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.